Organisation: Moderna

Moderna’s surprise EPO win is a boost for its flagging European patent assertions

But the covid-19 jab maker must overcome several more hurdles to get its hands on a slice of Pfizer/BioNTech’s vaccine revenues

20 May 2024

GSK becomes latest mRNA patentee to enter covid IP wars, increasing pressure on Pfizer/BioNTech

Meanwhile BioNTech and Moderna face off in the UK, and another mRNA spat settles

29 April 2024

BioNTech facing fresh mRNA spat in vaccine patent royalties dispute

The covid-19 IP war’s most prolific defendant finds itself on the brink of litigation in another fight

27 March 2024

mRNA firms and other biopharma patentees dominate ‘Innovation Momentum’ rankings

Newly released report throws light on which life sciences companies have the most dynamic IP portfolios

22 February 2024

mRNA trade secrets to become even more important, says WHO vaccine hub boss

IAM talked with Petro Terblanche, CEO of Afrigen Biologics, about the WHO vaccine hub and its IP strategy

21 February 2024

Five stories that made 2023 a momentous year for life sciences IP

The dawn of a new era for CRISPR patent strategy, multiplying mRNA patent wars, and 10x Genomics and NanoString’s cross-border spat were among the developments that defined the last 12 months

02 January 2024

MEPs seek SEP policy changes; EPO invalidates Moderna mRNA patent; patent pool royalty sharing; Panasonic interview; secondary patent market data; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days

26 November 2023

Top European patent owners 2022

Featured in Portfolio Data

Dolcera’s patent analysis takes a deep dive into Europe’s biggest players and reveals that the technology and manufacturing sectors are yet to realise their full potential.

23 November 2023

Key Moderna mRNA patent invalidated by EPO

The revocation has major implications for the covid-19 vaccine patent wars

21 November 2023

Moderna jab does not infringe Alnylam mRNA patents, finds US court

Meanwhile, Pfizer/BioNTech are taking aim at two Moderna patents

30 August 2023